Literature DB >> 12614448

Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity.

C E H Grattan1, G Dawn, S Gibbs, D M Francis.   

Abstract

BACKGROUND: The basopenia of chronic urticaria relates to histamine releasing autoantibodies in the serum of patients with autoimmune urticaria. This reduction in circulating basophils may be due to active recruitment into weals. If so, it might be expected that numbers in blood would be reduced when urticaria is active and increased after treatment. The primary aim of this study was to look at diurnal variation of basophil numbers in patients with chronic ordinary urticaria (not physical or vasculitic) in relation to disease activity and the effect of treatment with antihistamines and corticosteroids, and to compare the results with healthy controls. A secondary aim was to compare a standard manual counting method with automated basophil counts and to look at numbers of other circulating leucocytes that might be relevant to urticaria pathogenesis.
METHODS: Manual basophil counts using a toluidine blue stain and automated 5-part differentials (Coulter Gen. S) were performed at 4-hourly intervals from 08.00 to 20.00 in 10 healthy controls (six women, age 24 to 63 years) and seven chronic urticaria patients (five women, 24 to 50 years). All chronic urticaria patients had severe daily or almost daily urticaria. Only one of six chronic urticaria sera showed in vitro basophil histamine releasing activity. Counts were performed without treatment, after a week of taking loratadine 10 mg daily and after 3 days of adding prednisolone at 0.6 mg/kg/day (maximum 40 mg). Daily urticarial activity scores (UAS) were derived from weal numbers and itch, maximum 7.
RESULTS: There was no significant overall diurnal variation of basophil numbers in healthy controls or chronic urticaria patients. Mean (SE) manually counted basophil were higher in healthy controls than chronic urticaria (43.4/ microL (2.1) vs. 4.4 (0.8), P < 0.001). Basophil counts were reduced in healthy controls on steroids (19.2 (1.9), P < 0.001) but increased in chronic urticaria (8.9 (1.9), P < 0.001). Loratadine did not influence them. UAS fell on treatment (3.3 (0.4) baseline, 1.4 (0.5) on loratadine and 0.5 (0.2) on prednisolone with loratadine, P < 0.001). There was a negative linear correlation between basophil numbers and UAS in untreated chronic urticaria patients (P = 0.001, Spearman rank correlation). Manual and automated basophil counts showed poor agreement. Lymphocyte numbers were lower in chronic urticaria than healthy controls. Neutrophils increased whereas lymphocytes and eosinophils decreased in all subjects on prednisolone. They were unaffected by loratadine.
CONCLUSION: The results are consistent with the hypothesis that circulating basophils may be recruited from blood into urticarial weals during disease activity. Automated counts are not suitable for assessing basophil numbers in chronic urticaria. The relevance of reduced lymphocyte numbers in chronic urticaria needs to be explored.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614448     DOI: 10.1046/j.1365-2222.2003.01589.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  34 in total

1.  Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.

Authors:  Eric Tyrell Oliver; Kris Chichester; Kelly Devine; Patricia Meghan Sterba; Craig Wegner; Becky Marie Vonakis; Sarbjit Singh Saini
Journal:  Int Arch Allergy Immunol       Date:  2019-03-15       Impact factor: 2.749

2.  A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

Authors:  Marco Folci; Giacomo Ramponi; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

Review 4.  Aeroallergens in Atopic Dermatitis and Chronic Urticaria.

Authors:  Albert C Chong; Won Jong Chwa; Peck Y Ong
Journal:  Curr Allergy Asthma Rep       Date:  2022-04-01       Impact factor: 4.806

Review 5.  Chronic Spontaneous Urticaria: The Devil's Itch.

Authors:  Sarbjit S Saini; Allen P Kaplan
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

6.  Progress and challenges in the understanding of chronic urticaria.

Authors:  Marta Ferrer; Allen P Kaplan
Journal:  Allergy Asthma Clin Immunol       Date:  2007-03-15       Impact factor: 3.406

Review 7.  Basophil responsiveness in chronic urticaria.

Authors:  Sarbjit S Saini
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 8.  Basophils and skin disorders.

Authors:  Francesco Borriello; Francescopaolo Granata; Gianni Marone
Journal:  J Invest Dermatol       Date:  2014-02-06       Impact factor: 8.551

Review 9.  Current and emerging treatments for chronic spontaneous urticaria.

Authors:  Kirti J Johal; Sarbjit S Saini
Journal:  Ann Allergy Asthma Immunol       Date:  2019-09-05       Impact factor: 6.347

Review 10.  New concepts in chronic urticaria.

Authors:  Becky M Vonakis; Sarbjit S Saini
Journal:  Curr Opin Immunol       Date:  2008-10-17       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.